摘要 |
The present invention provides a method for enhancing the level of perfusion of blood to a nonischemic skeletal muscle, e.g., by inducing angiogenesis or collateral blood formation in a nonischemic skeletal muscle at risk of being affected by ischemia or a vascular occlusion, by administration of a pharmaceutical composition comprising a DNA encoding an angiogenic peptide, such that the level of perfusion of blood to the nonischemic skeletal muscle is enhanced.
|